TechNet-21 - Forum

This forum provides a place for members to ask questions, share experiences, coordinate activities, and discuss recent developments in immunization.
  1. Moderator
  2. Announcements
  3. Monday, 05 August 2013
Umit Kartoglu, WHO WHO/EPELA e-Pharmaceutical Cold Chain Management courses will be starting in September. We encourage both public and industry sector representatives to apply online. E-Pharmaceutical Cold Chain Management course dates: 23 September – 13 December 2013 6 January – 28 March 2014 31 March – 20 June 2014 1 September – 21 November 2014 The e-Pharmaceutical Cold Chain Management course takes participants inside an enhanced, robust mental model of a pharmaceutical cold chain. For 12 weeks, we travel with participants virtually from one location to another, through different levels of the supply chain. In addition to the virtual visits to real facilities, we offer short illustrated videos and critical reference materials. Authentic tasks are arranged mainly as group activities to promote collaborative learning and enhanced with peer-review. The course site offers participants tools to help to easily connect with other participants, discuss and produce as a team. Mentors provide timely feedback to all participants whenever necessary and are always ready to assist them whenever participants need them. Following 7 weeks of virtual visits to real facilities, participants are introduced as a group to a real client so that together with their peers they can analyse, report and give recommendations to the client regarding the client’s operation of the time and temperature-sensitive pharmaceutical products. For details of the course, please visit: To apply online for the course please visit: The new course on VVM-based vaccine management will go for beta-test between 21 October-20 December 2013 and will start accepting participants for its 2014 schedule (to be announced soon with the online application tool). Looking forward to hear from you. Cheers UMIT KARTOGLU Course Director

There are no replies made for this post yet.
Be one of the first to reply to this post!